Cross-linked Protein A Crystals for Antibody Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying antibodies are inefficient due to high protein leaching and instability of Protein A, leading to increased costs and production time, and require additional support materials for chromatography.
Innovation Solution
Development of cross-linked Protein A crystals (CLPCs) that are more stable and have higher binding capacity, reducing protein leaching and eliminating the need for additional support materials, achieved through cross-linking with glutaraldehyde and using in chromatography systems.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If Protein A is used in conventional chromatography systems, then antibody purification can be achieved, but protein leaching occurs and stability is poor
Solution Approach 1:
The patent applies preliminary action by cross-linking Protein A molecules before they are used in chromatography. The cross-linking process is performed in advance to create stable Protein A crystals that resist leaching during subsequent antibody purification operations. This preliminary chemical modification ensures protein stability and prevents loss of Protein A throughout the purification process.
Solution Approach 2:
The patent creates composite materials by forming cross-linked Protein A crystals where multiple Protein A molecules are chemically bonded together through cross-linking agents. This composite structure combines the binding properties of Protein A with the structural stability of cross-linked networks, resulting in crystals that maintain protein integrity and prevent leaching while retaining antibody purification functionality.
2Device complexity
If conventional Protein A systems are used, then purification can be performed, but additional support materials are required
Solution Approach 1:
The patent extracts and eliminates the need for additional support materials by incorporating the support function directly into the Protein A crystal structure itself. The cross-linked Protein A crystals serve as both the binding medium and the structural support, removing the requirement for separate carrier materials such as agarose or sepharose that are traditionally used in chromatography systems.
Solution Approach 2:
The patent achieves multi-functionality by designing Protein A crystals that simultaneously provide antibody binding, structural support, and column packing functions. The cross-linked crystal structure serves multiple purposes: it acts as the functional binding medium for antibodies, provides mechanical strength as structural support, and can be packed into columns for chromatography operations, eliminating the need for separate specialized materials for each function.
3Productivity
If conventional chromatography systems are used, then antibody purification is achieved, but production time and costs increase
Solution Approach 1:
The patent applies parameter changes by modifying the physical and chemical properties of Protein A through cross-linking and crystallization. These parameter changes result in crystals with enhanced binding capacity, improved stability, and reduced leaching, which collectively improve purification efficiency and reduce the time and resources required for antibody production while maintaining high productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The cross-linked Protein A crystals provide enhanced stability and binding capacity, reducing antibody production time and costs by minimizing protein leaching and eliminating the need for additional support materials in chromatography systems.
Implementation Method 1
Protein A bind proteins from many mammalian species, most notably IgGs. It binds with the Fc region of immunoglobulins through interaction with the heavy chain.
Implementation Method 2
The cross-linking of Protein A crystals can prevent or decrease the leaching of Protein A during purification (e.g., using chromatography). In a further embodiment, the Protein A crystal is cross-linked with about 0.02% to about 4% (w/v) glutaraldehyde.
Data Source
AI summary
Protein A crystals and Protein A cross-linked protein crystals (CLPCs) are described. Methods of preparing and using are also disclosed.